Chemed Balanced Scorecard

It works best as a cross-segment dashboard for financial health, service quality, and execution discipline. For Chemed's 2 businesses, the most useful indicators are revenue growth, margin, patient or customer satisfaction, and compliance. That mix matters because VITAS and Roto-Rooter have very different operating models and risk profiles.

It should use segment-specific targets rather than one generic template. VITAS needs patient census, referral quality, and compliance indicators, while Roto-Rooter needs call conversion, technician utilization, and job completion speed. Keeping both under one corporate view helps management compare results without forcing the same operating model on both units.

The biggest benefit is keeping care quality visible alongside financial performance. In hospice, indicators like family satisfaction, documentation accuracy, and referral consistency matter as much as occupancy or revenue. That balance is especially useful for VITAS because it is the largest hospice provider in the United States and operates in a highly sensitive care setting.

The main drawbacks are metric overload, hard-to-measure outcomes, and inconsistent data across locations. Hospice quality and plumbing service quality are not equally easy to quantify, so managers can end up chasing proxy metrics instead of the real drivers. That risk is higher when one company oversees 2 very different service businesses.

Execution discipline limits it more than the framework itself. If managers do not refresh targets, review trends monthly, and tie scores to staffing or training, the scorecard becomes a reporting exercise. Chemed's two segments also face different cycles, so the framework works best when each unit tracks the metrics that actually move customer outcomes and margin.